NIH-funded research R01 grant

Investigating how glutamate transport affects blood flow in Alzheimer's disease

Official title: Dysregulation of glutamate transporter-dependent neurovascular coupling in Alzheimer's disease

Funded at Drexel University · NIH-11013945 · Data updated 2026-11-12

This study is looking at how problems with a brain chemical called glutamate might affect blood flow and energy use in the brains of people with Alzheimer's, with the hope of finding new ways to help improve thinking and memory.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDrexel University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startApril 15, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$422,064
NIH project number5R01AG081929-03
Project IDNIH-11013945 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those exhibiting early signs of cognitive decline.

Less likely to help

Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.

What this research studies

This research explores the relationship between glutamate transport and neurovascular coupling in Alzheimer's disease. It aims to understand how disruptions in glutamate transport can lead to decreased blood flow and glucose metabolism in the brain, which may contribute to cognitive decline. The study will utilize advanced techniques to assess the functioning of astrocytes and their role in regulating blood vessel diameter in response to glutamate. By examining these mechanisms, the research seeks to uncover potential targets for therapeutic intervention.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for improving blood flow and metabolic function in patients with Alzheimer's disease.

How similar studies have gone: Previous research has shown promising results in understanding neurovascular coupling in other neurodegenerative conditions, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Drexel University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Jackson, Joshua Goodyear — Drexel University
  • Study coordinator: Jackson, Joshua Goodyear

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.